Latest

UK Regenerative Medicine Platform (Stage I) – Immunomodulation Hub

July 30, 2013

The Biotechnology and Biological Sciences Research Council (BBSRC), Engineering and Physical Science Research Council (EPSRC) and Medical Research Council (MRC) are establishing a £25M UK Regenerative Medicine Platform (UKRMP) to address the technical and scientific challenges associated with translating promising scientific discoveries in this area towards clinical impact.

At its core, the first stage of funding supports interdisciplinary and complementary Research Hubs that together will provide a world-leading programme to promote the development of regenerative therapies by addressing key translational gaps.

To complement the recently established Hubs, the RC sponsors are inviting proposals to establish a high quality, collaborative research grouping that can assemble the capability needed to address key immune challenges in translational regenerative medicine, focussed on harnessing immunomodulatory approaches. Up to £2M is available for the successful bid.

This is a revised call from that advertised in September 2012, with a broader remit informed by an Immunology/Stem Cell Workshop  held on the 5th July 2013.

For further details please see the UKRMP Call for Proposals website: www.ukrmp.org.uk

Funded by

BBSRC
epsrc
MRC